Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity

Katharina Hopp(Mayo Clinic), Peter C. Harris(Mayo Clinic)

Journal of Clinical Investigation

October 15, 2012

10.1172/jci64313

Cited by 444

Related Papers

Mutations in GANAB , Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease

|The American Journal of Human Genetics|2016|463

Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease

|The American Journal of Human Genetics|2018|310

Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner

|Journal of Clinical Investigation|2015|133

PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease

|Scientific Reports|2019|79

A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with Autosomal Dominant Polycystic Kidney Disease

|BMC Nephrology|2015|32